← FDA Drug Approvals (Drugs@FDA)
RENOCAL-76
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BRACCO · Approved 1988-06-01
Drug application
- FDA Application #
ANDA089347- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RENOCAL-76
- Generic name
- Diatrizoate Meglumine
- Active ingredients
- DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- BRACCO
- First approval
- 1988-06-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown